Aesthetics

Affordable at-home treatments, including microneedling and benzoyl peroxide, were top pearls at Chilukuri's Elevate-Derm session.

Researchers noted that ethical use of AR and VR in cosmetic care requires balancing technological benefits with patient safety and privacy.

Bob Rhatigan, CEO of Merz Aesthetics, discusses the organization’s commitment to advancing the aesthetics industry through strategic partnerships, specialized training, and a growing portfolio of injectables and devices.

Manson Brown discusses Allergan Aesthetics' Science of Aging program, highlighting its role in shifting from anti-aging to pro-longevity in aesthetic medicine.

A study of the new cleanser included diverse participants, ensuring it is suitable for various skin types and sensitivities.

At Fall Clinical 2024, Ablon shared her top device-based interventions, from wound care to radiofrequency rejuvenation, revealing clinical pearls for enhanced aesthetic outcomes.

Developed by a panel of global dermatology experts, the SQS addresses the multifaceted nature of skin quality.

In this month's Cosmetic Conundrums column, explore 4 eyelash growth scenarios.

Along with this new transparency regarding treatments, patients are empowered to embrace more comprehensive beauty ideals.

Robb delved into how the system is transforming skin treatments with advanced precision, faster results, and improved patient outcomes.

Peptides are increasingly used in cosmeceuticals for their ability to enhance cellular communication and functionality in antiaging formulations.

Misleading marketing and incomplete scientific data have led to widespread misinformation about botulinum toxin products.

At T0, skin layers appeared normal, and at T1, filler deposits were clearly visible as hyporeflective areas.

The use of microneedling, however, resulted in decreases in pigmentation and pruritus.

Zoe Draelos, MD, presents vignettes based on common hair problems that patients face, with possible dermatologic solutions.

Omer Ibrahim, MD, discusses the nuances of aesthetic procedures for patients with skin of color and the importance of tailored treatments, safety, and improved clinician education.

The new indication adds to existing clearances for hemostasis and electrocoagulation.

Sachin Shridharani, MD, FACS, discusses the READY-1 and READY-2 clinical trials and positive support for Relfydess.

ND-ZnO technology also demonstrated substantial skin permeation and active ingredient delivery.

A group of international experts focused on the technology’s potential to standardize and enhance patient assessments.

Explore solutions for facial volume loss, skin laxity, and in some cases—skin excess.

Researchers noted that many dermatologists face mild, non-life-threatening complications during procedures, yet must be prepared for emergencies.

Zoe Diana Draelos, MD, examines common questions and controversies regarding physiologic differences in skin between White, African American, and Hispanic individuals.

Walter Liszewski, MD, shares insights into discrepancies between permanent makeup and decorative tattoos and which patients may benefit from permanent makeup.

The recent news of counterfeit Botox resulted in patients with blurred vision, difficulty swallowing, shortness of breath, and additional symptoms.

In this month's Cosmetic Conundrums column, Zoe Diana Draelos, MD, examines the most popular active ingredients in redness-reducing formulations.

Robin Siperstein, MD, FAAD, shares practical tips in cosmetic dermatology at the 2024 SDPA Annual Summer Dermatology Meeting.

In this month’s Cosmetic Conundrums column, explore what dermatology clinicians need to know about false eyelashes to help prevent infections or contact dermatitis.

These results are indicative of the need for dermatologists to discuss social media misinformation and low quality information with their patients.

This week’s collection of the latest dermatologic studies includes artificial intelligence in cutaneous lesions, dupilumab-induced acanthosis nigricans, aesthetic considerations for treating lesbian, gay, and bisexual patients, and monotherapies for male androgenetic alopecia.